To further confirm whether inhibiting necroptosis is capable of ameliorating depression, we will explore whether GSK872, a RIPK3 inhibitor, ameliorates the depressive-like behavior of CUMS-exposed rats. Here, RIPK3 is linked to depressive disorder.